Stonepine Capital Management, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$12,834,000
+56.5%
3,130,192
+36.3%
5.32%
+41.4%
Q4 2021$8,202,000
+753.5%
2,297,360
+769.9%
3.76%
+761.3%
Q3 2021$961,000
-70.5%
264,100
-78.1%
0.44%
-87.1%
Q3 2020$3,255,000
+811.8%
1,205,501
+697.3%
3.39%
+795.8%
Q1 2020$357,000151,1890.38%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders